Another solution for antibiotic resistance is the development of new drugs that defeat resistant bacteria. Such research and development has a high fixed cost and can only be undertaken in industries with high market concentration where firms have significant monopoly power, like the pharmaceutical industry.

Examine this industry using the theory and models of industry structure. Should government be worried about any aspect of how an industry with this market structure will perform?